Immunovative Clinical Research, Inc.
Wholly owned US subsidiary of Immunovative Therapies, Ltd.
Wholly owned US subsidiary of Immunovative Therapies, Ltd.
Immunovative Clinical Research, Inc. is a pioneering private consulting company in the biotechnology and healthcare industries. Founded in 2004, the company is a wholly owned US subsidiary of Immunovative Therapies, Ltd. Offering a range of services including clinical research, blood donor operations, and site management, Immunovative Clinical Research, Inc. has been dedicated to pushing the boundaries of medical research and treatment. Their commitment to innovation has recently attracted a major $12.00M Venture Round investment on 20 January 2012, led by Trendlines Group and Misgav Technology Center. Based in the United States, the company's vision and recent funding make it a compelling player to watch in the evolving landscape of healthcare and biotechnology startups.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $12.00M | 2 |
|
20 Jan 2012 |
| Venture Round | $3.00M | - | 01 Jan 2008 | |
| Seed Round | $500.00K | 1 | Malcolm Currie | 04 Mar 2007 |
| Seed Round | $1.00M | 2 |
|
01 Jan 2004 |
No recent news or press coverage available for Immunovative Clinical Research, Inc..
We care about your data, and we'd love to use cookies make your experience better.
